SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001544784-19-000003
Filing Date
2019-05-10
Accepted
2019-05-10 16:04:32
Documents
68
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ymab-20190331x10q.htm 10-Q 1617303
2 EX-31.1 ymab-20190331ex311d00cda.htm EX-31.1 20162
3 EX-31.2 ymab-20190331ex3125a4a29.htm EX-31.2 20060
4 EX-32.1 ymab-20190331ex321e73299.htm EX-32.1 9832
5 EX-32.2 ymab-20190331ex322fdeee1.htm EX-32.2 9790
  Complete submission text file 0001544784-19-000003.txt   4485722

Data Files

Seq Description Document Type Size
6 EX-101.INS ymab-20190331.xml EX-101.INS 546361
7 EX-101.SCH ymab-20190331.xsd EX-101.SCH 45755
8 EX-101.CAL ymab-20190331_cal.xml EX-101.CAL 37876
9 EX-101.DEF ymab-20190331_def.xml EX-101.DEF 138071
10 EX-101.LAB ymab-20190331_lab.xml EX-101.LAB 357999
11 EX-101.PRE ymab-20190331_pre.xml EX-101.PRE 296091
Mailing Address 750 THIRD AVENUE 9TH FLOOR NEW YORK NY 10017
Business Address 750 THIRD AVENUE 9TH FLOOR NEW YORK NY 10017 212-847-9841
Y-mAbs Therapeutics, Inc. (Filer) CIK: 0001722964 (see all company filings)

IRS No.: 474619612 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38650 | Film No.: 19814835
SIC: 2834 Pharmaceutical Preparations